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The Ia glycoproteins, encoded by the I-A and I-E regions of the murine major 
histocompatibility complex (MHC), are the immune response (Ir) gene products. 
As a  result, theories of Ir gene control can be analyzed by comparing immune 
responses of mice that have a  defined mutation in an I  region gene with those 
made by wild-type animals. The LA  b mutant B6.C-H-2  ~12 (bml 2) and their wild- 
type counterpart C57BL/6 (B6) mice provide such a model system. Biochemical 
studies (1, 2) reveal that the mutant mouse has three peptide substitutions in the 
A~ chain, while the A b chain seems to be unchanged. DNA sequencing of the 
I-A~  ml2 gene shows (3) three nucleotide differences in the first domain which are 
clustered within a  stretch of 14 nucleotides coding for amino acid residues 67- 
71 of the mature polypeptide. 
The reactivity profile of bm 12 mice to antigens that are known to be under Ir 
gene control mapping to LA  b has been studied. As shown in Table I, despite the 
mutation,  the  general  Ir  phenotype  characteristic  of LA  b mice  was  retained. 
However, bm 12 mice are unresponsive to H-Y antigen (4) and beef insulin (5), 
compared with the B6 wild-type. Our results suggest that the mutation affected 
a  discrete functional domain on the A~ chain. Our recent data (6) revealed that 
bml2 mice possess an insulin-specific immune potential. Therefore, we consid- 
ered  that  the alteration  of the  nucleotide sequence  may not have  resulted  in 
complete unresponsiveness, but rather in a  change in the fine specificity of the 
immune response to these antigens. Heterologous insulins are useful because H- 
2 b mice respond with strong T  cell proliferation and antibody responses only to 
beef insulin, whereas H-2  k mice respond to sheep and horse insulin (Table  II; 
references 7-1 1). These types of insulin differ at a single amino acid in position 
9 of the A chain loop (Table II). 
Materials and Methods 
Mice.  C57BL/6 and B10.A mice were purchased from The Jackson Laboratory, Bar 
Harbor,  ME.  B10.A(4R) and  B10.A(5R)  mice, and  B6.C-H-2 b=j2 breeding pairs  were 
kindly supplied by Dr. M. Dorf, Harvard Medical School and Dr. J. Forman, University 
of Texas Southwestern Medical School, respectively. Mice were used at 5-7 wk of age. 
Antigens.  Insulins (Sigma Chemical Co., St. Louis, MO) were dissolved in 0.5% sodium 
carbonate and  adjusted to  1 mg/ml with phosphate-buffered saline.  Purified protein 
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derivative of mycobacteria was purchased  from Connaught Research Laboratories,  To- 
ronto, Canada. 
Immunizations.  Mice  were injected in the hind footpads and in the base of the tail with 
an  emulsion  of insulin  in  complete  Freund's adjuvant (H37Ra)  (Difco Laboratories, 
Detroit,  MI) containing  0.5 mg/ml killed Mycobacterium tuberculosis. 50 #g of insulin in 
0.1 ml of emulsion were injected into the three sites. 
Antigen-specific T  Cell Proliferation Assays.  7-14  d after immunization,  the draining 
popliteal, paraaortic, and inguinal lymph nodes, or peritoneal exudate cells induced with 
thioglycollate, were collected. Cells were placed in single-cell suspension and T  lympho- 
cytes were enriched in a nylon wool-nonadherent fraction.  2 ×  105 T  cells were then 
incubated in 96-well microtiter plates for 96 h (37°C incubator,  5% CO2 in air) with 10  "~ 
irradiated (2,000 rad) syngeneic spleen cells (serving as antigen-presenting cells [APC]) in 
a final volume of 0.2 ml RPMI  1640 supplemented  with 10% heat-inactivated fetal calf 
serum, 2-mercaptoethan01, glutamine, penicillin, streptomycin and Hepes buffer. Antigens 
were present at a final concentration of 100 t~g/ml. During the final 18 h of culture, each 
well was pulsed with 1 #Ci of tritiated thymidine (30 Ci/mM; ICN Pharmaceuticals, Inc., 
Irvine, CA). Cells were harvested on glass fiber filter paper using a microharvester (MASH 
II). Thymidine incorporation  is reported as the mean counts  per  minute of triplicate 
samples. Underlined values in  the tables are significant (P <  0.01)  according  to the 
Student's t test. 
Results 
bm 12 Mutation Alters the Specificity of  Insulin Recognition.  B6, bm 12, and B 10.A 
mice were injected with beef or sheep insulin, and the ability of their primed T 
cells  to  proliferate  in  vitro  upon  challenge  with  insulin  was  assessed.  One 
proliferation study with beef insulin-primed cells (Table III) confirms previous 
data (7-11)  indicating that B6, but not bml2 or B10.A, mice respond to beef 
insulin (summarized in Table II). Proliferation studies with sheep insulin-primed 
T  cells are represented by three experiments (Tables III and IV). Sheep insulin- 
immune T  cells from bm 12 mice proliferated upon challenge with sheep insulin. 
As expected, such a  response was obtained with B10.A but not with B6  mice. 
Thus, the bml2 mice, like B10.A mice (which are H-2k), are responders to sheep 
insulin. It should be noted that T  cells  of sheep insulin-primed B6 and bml2 
mice responded to challenge with beef insulin in vitro, although the immune T 
cells from the B 10.A mice did not. Such priming by "forbidden" insulin variants 
has been reported previously (9) for H-2  b mice. This is another example of the 
general retention of the I-A  b Ir phenotype by bm 12 mice. 
Ir  Gene for  the  Sheep  Insulin  Response  of H-2  k Mice  Maps  to  the  I-E  Subre- 
gion.  Having shown that bml2  mice, like B10.A mice, respond to sheep but 
TABLE  I 
lmmune Response Pattern of H-2 b Wild-type and Mutant Mice, and H-2 ~ Recombinant Mice 
MHC haplotype  H-Y  Beef  Sheep 
(PHE,G)-A--L  (T,G)-A--L  (H,G)-A--L  anti-  insu-  insu- 
A0  A~  E  a  E~  gen  lin  lin 
B6 H~2  b  b  b  b  b  High  High  Low  High  High  Low 
bm 12 H-2 bmj~  bm 12  b  b  b  High  High  Low  Low  Low  High* 
BI0.A H-2 k  k  k  k  k  High  Low  High  +/-  Low  High 
B10.A(4R)  H°2  h4  k  k  k  b  High  Low  High  +/-  Low  Low* 
Data are compiled from references 6-16. 
* As determined in this paper. 
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TAB~.E  II 
Ir Gene Control of  Murine Response to Insulins 
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MttC haplotype 
Amino acid sequences of heterologous insulins 
Species  A CHAIN  B CHAIN 
11-2  b=l~  H-2  b  H-2  ~  H-2  a  A4  A8  A9  AI0  B4  B10  B31 
....  Mouse  Asp ......  Thr  Ser  lie - - -  Lys .....  Pro ......  Ser 
+*  -  +  +  Sheep, Horse  Glu ......  Ala  Gly  Val - - -  Ash .....  Ser ......  Ala 
-  +  -  +  Beef  Glu ......  Ala .......  Val  - - -  Asn .....  Ser ......  Ala 
-  -  -  +  Pork  Glu .....................  Asn .....  Ser ......  Ala 
1)ata are compiled from references 9-12. 
* As  determined in this paper. 
TABLE  III 
Response  of the LA b Mutant  bml2  and  Wild-type B6 Mice to Beef and Sheep Insulin 
Antigen 
Beef insulin-primed T  cells 
Sheep insulin-primed T  cells 
Experiment 1  Experiment2 
B6  bm 12  B6  bm 12  B6  bm 12 
--  4,332  2,187  4,073  5,773  2,661  3,798 
Sheep  5,292  3,487  5,334  18,334  5,284  12,361 
Beef  12,731  4,332  15,724  ~  12,453  28,105 
Pork  ND  ND  3,433  8,684  3,124 
PPD  21,349  33,979  35,438  62,139  34,114  30,145 
Data represent cpm tritiated thymidine incorporated.ND, not determined. 
TABLE  IV 
I Region Restriction of the Immune Response to Sheep Insulin 
Sheep insulin-primed T  ceils: 
Antigen  Experiment  1  Experiment 2 
BI0.A(4R)  B10.A  B6  bml2  BI0.A(4R) 
--  3,174  3,057  4,604  8,776  5,819 
Sheep  2,906  11,793  7,329  28,284  4,682 
Beef  3,452  3,1~'g  23,649  40,242  6,113 
PPD  37,527  36,296  ~  ~  41,385 
Data represent tritiated thymidine incorporated. 
not beef insulin,  we considered that the bm 12 mutation arose by an intergenic 
exchange of H-2  b- and H-2k-like sequences. To define the origin of the putative 
donor sequence, we compared the sheep insulin  response of H-2  k recombinant 
B10.A  k  k  k  k  (AoA~EoE~) mice.  As shown in Table  IV, T  (AoA~EoE~) and  B10.A(4R)  k  k  k  b 
cells from sheep insulin-primed  B 10.A(4R) mice did not proliferate upon chal- 
lenge in vitro with sheep insulin. Since B 10.A(4R) mice express only A~,0 chains, 
responsiveness to sheep insulin in H-2  k mice must map to the E~,0 complex. This 
conclusion was confirmed by studies (data not shown) in which the proliferation 
of sheep  insulin-primed  T  cells  derived  from  H-2  k CBA  and  A/J  mice  was 
blocked by the addition of monoclonal antibodies directed against the E  k but not 
the A k molecule. The E~ gene is likely to control the response of H-2  k mice to 
sheep insulin,  since the E~ gene is virtually nonpolymorphic. 
Sheep Insulin Recognition Maps to the Ia Epitope 67-71, Expressed by ab,,le/vk /~,b  -'a  B  11:,#11:,  B 1928  HOCHMAN  AND  HUBER  BRIEF  DEFINITIVE REPORT 
TABLE V 
Eab/Eak/Aa  b~12 Ia Epitope Controls the Immune Recognition of Sheep Insulin 
Sheep insulin-primed T cells 
APC  Insulin  bm  12 
BIO.A 
Exp. 1  Exp. 2 
B 10.A  --  2,581  9,031  13,842 
Sheep  7,593  13,419  21,116 
Pork  1,904  T,586 
bml2  --  4,201  5,170  7,029 
Sheep  9,031  15,129  13,365 
Pork  ~  ~,545  10  ,-'6-,-,-,-,-,-,~ 
B 10.A(5R)  --  3,910  8,933  ND 
Sheep  14,465  17,294  ND 
Pork  ~  ~  ND 
Data represent counts per minute tritiated  thymidine  incorporated.  ND, not determined. 
67-71.  The mapping of the sheep insulin response of H-2  k mice to the I-E~ gene 
suggests that, if the bm 12 mutation arose by a gene conversion event, the donor 
sequence  was  derived  from  the  second  exon  of the  I-E~  gene  (12),  which  is 
homologous at the bml 2  mutation  site, and  its flanking  regions,  to the I-A~  "12 
(3) and I-Ek~ (13) genes. To assess whether the amino acid cluster 67-71  controls 
recognition and/or presentation of sheep insulin, and whether bm 12 and H-2 k T 
cells  recognize  the  same  sheep  insulin  determinant  in  the  context  of this  Ia 
epitope, sheep insulin-immune  bml2 and B I0.A peritoneal T  cells were chal- 
lenged  in  vitro  with  sheep  insulin  presented  by bml2,  B10.A,  or  B10.A(5R) 
APC. These APC express Abml2Ab vkvk  b  k  ~0  ~,~0L~, and EoE~ Ia molecules, respectively. As 
shown in  Table V, sheep insulin-immune  bml2 and  B10.A T  cells responded 
to sheep, but not pork, insulin presented by either of these three APC. 
Discussion 
We have shown that the mutation in the 1-At gene results in the expression of 
an Ir gene epitope that allows for an/-A-restricted  immune  response to sheep 
insulin (since the bm 12 mice do not express an E molecule). The bm 12 mutation 
then  defines  the  actual  nucleotide  sequence  controlling  the  specificity of the 
immune response to this nominal antigen. Moreover, the insulin system provides 
for a  very precise correlation  between such  nucleotide sequences and  various 
insulin determinants,  dependent upon a single amino acid change (Table I). 
The observation that  three substitutions in the first domain of the A~ chain 
result in an alteration of the specificity of immune recognition, such that bm 12 
mice respond to sheep but not beef insulin,  suggests that the association of beef 
insulin-unique  determinants  with  A~  m12 resembles self, while the association of 
sheep insulin-specific  determinants  is significantly different from self, so as to 
allow T  cell activation.  We have shown previously (6) that such "self-reactive', 
beef insulin-specific T  cells can be rescued by hybridization from beef insulin- 
immune bm 12 mice. 
Sheep insulin  recognition  by bml 2 mice and the mapping of the Ir gene for 
the  sheep  insulin  response  of H-2  k  mice  to  the  I-E  subregion  correlate  with 
reports of DNA sequence homology of the I-A~  "12 (3), I-E~ (12), and I-E~ (13) 
genes at the sites where the I-A b'~2 differs from the LA b gene. These functional HOCHMAN AND HUBER  BRIEF  DEFINITIVE REPORT  1929 
and sequencing data, therefore, strongly suggest that the bm 12 mutation arose 
by  a  gene  conversion event in  which  there  was  a  transfer  of I-E~  nucleotide 
sequences to the I-At gene, resulting in a  sheep insulin-specific Ir gene epitope 
on the A~  m12 molecule. Indeed, our observation of sheep insulin recognition by 
B 10.A and bm 12 sheep insulin-specific T  cells in the context of B10.A, bm 12, 
and, most notably, B10.A(5R) APC that express the A~  ml~, El, and E~ epitopes, 
respectively,  substantiates  this  hypothesis.  Since  there  is  very  little  sequence 
homology between  A b and  E k molecules, or between  A~  m12 and  El molecules 
except for the conserved region 67-71, the bml 2 mutation site forms the actual 
Ir gene epitope. Furthermore, the antigen cross-presentation by the three differ- 
ent APC strongly suggests that the bm 12 mutation defines a  "histotope"; i.e., a 
T  celi-Ia interaction site. This is further substantiated by our previous findings 
(6) that the majority of B6 and bm 12 T  cell clones, regardless of their antigen 
specificity, respond to antigen in the context of their own APC only. 
It is of particular interest that, although APC of B 10.A(5R) mice phenotypically 
express the sheep insulin-specific E b epitope, their sheep insulin-primed T  cells 
do not proliferate when challenged in vitro with sheep insulin, but rather,  like 
sheep insulin-primed T  cells of B6 mice, proliferate upon challenge with beef 
insulin (data not shown). The failure of the B10.A(5R) mice to respond to sheep 
insulin may reflect preferential recognition of insulin in the context of I-A n rather 
than I-E b gene products upon priming in vivo and/or subsequent challenge in 
vitro, as has been reported (15)  for the response of H-2  k mice to L-tyrosine-p- 
azobenzenearsonate. Alternatively, the failure of B 10.A(5R) mice to respond to 
sheep insulin  may reflect  a  hole  in  their  insulin-specific T  cell  repertoire  or 
epitope-specific suppression. These points are currently being investigated. 
Finally,  not  all  functional  Ia  recognition  units  were  altered  by  the  bml2 
mutation, which is reflected in the apparent retention of the LA b reactivity profile 
by the mutant. Our observation that sheep insulin-primed bml2 T  cells prolif- 
erate upon challenge, not only with sheep insulin, but also with beef insulin, as 
do sheep insulin-primed B6 T  cells, supports the existence of multiple functional 
domains on Ia molecules (16). 
Summary 
To  assess the  role  of  Ia  epitopes  in  conferring  specificity  for  the  immune 
response to nominal antigen, we compared the insulin response of mice with a 
defined mutation in the I-A t  gene, the B6.C-H-2  b'le (bml2), with that of wild- 
type H-2 b C57BL/6 (B6) mice. We report that the bml2 mutation resulted in a 
selective alteration of the specificity of insulin recognition, such that bml 2 mice 
responded upon immunization with sheep but not beef insulin, which differ by 
only  one  amino  acid  at  position  9  of the  insulin  A  chain.  Thus,  the  bml2 
mutation allows for the definition of the actual nucleotide sequence coding for 
an  Ia  epitope  that  is  responsible  for  controlling  the  specificity  of  immune 
recognition of insulin. Furthermore, we show that the sheep insulin response of 
H-2 k mice is controlled by the E molecule and that sheep insulin can be recognized 
by primed bml2  and H-2  ~ T  cells in  the context of either  bml2,  B10.A,  or 
B10.A(5R)  antigen-presenting cells.  Our data suggest that the mechanism for 1930  HOCHMAN  AND  HUBER  BRIEF  DEFINITIVE  REPORT 
the bm 12 mutation was the intergenic transfer of a  hypervariable region in the 
first domain that is identical in the I-A~  "~12, I-E~, and I-E~ genes. 
Received for publication  20 August 1984 and in revised form 26 September 1984. 
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